Oximetry reveals abnormal oxygen metabolism in exudative AMD

Article

Professor Stef?nsson reveals the results of a comparative study demonstrating that observation of metabolic processes is possible enabling insight into the pathophysiology of disease.

The design of the non-invasive retinal oximeter is based on a fundus camera. It simultaneously captures images of the retina at 600 nm and 570 nm and estimates retinal vessel oxygen saturation, then producing an image in which the degrees of oxygen saturation are indicated by different colours.

To establish whether the retina metabolises oxygen differently in an eye with AMD than in a healthy eye, the Oximetry Group in Reykjavik, including Asbjorg Geirsdottir, Sveinn Hakon Hardarson and professor Einar Stefánsson (University of Iceland, National University Hospital, Reykjavik, Iceland) compared the oximetry images of healthy eyes with those of eyes with exudative AMD.

When oxygen saturation in AMD patients is compared with healthy individuals a statistically significant difference is seen. While the venous oxygen saturation of healthy individuals decreases with age, in AMD patients the opposite pattern is seen.

He continued, "The preliminary results indicate that oxygen metabolism is different in healthy and AMD eyes."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
© 2025 MJH Life Sciences

All rights reserved.